Yudong Li
- Topics
- Breast Cancer Treatment Studies (6 papers)Advanced Breast Cancer Therapies (4 papers)HER2/EGFR in Cancer Research (3 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Yudong Li
32 papers receiving 896 citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Molecular Biology 341
- Oncology 180
- Cancer Research 120
- Surgery 115
- Materials Chemistry 115
Countries citing papers authored by Yudong Li
This map shows the geographic impact of Yudong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yudong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yudong Li more than expected).
Fields of papers citing papers by Yudong Li
This network shows the impact of papers produced by Yudong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yudong Li. The network helps show where Yudong Li may publish in the future.
Co-authorship network of co-authors of Yudong Li
This figure shows the co-authorship network connecting the top 25 collaborators of Yudong Li. A scholar is included among the top collaborators of Yudong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yudong Li. Yudong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancersbreakdown → | 87 |
| 4 | 0 | |
| 5 | 4 | |
| 6 | 66 | |
| 7 | 44 | |
| 8 | 20 | |
| 9 | 6 | |
| 10 | 2 | |
| 11 | 12 | |
| 12 | 110 | |
| 13 | 9 | |
| 14 | 42 | |
| 15 | 15 | |
| 16 | 95 | |
| 17 | 13 | |
| 18 | 9 | |
| 19 | 15 | |
| 20 | 28 |
About Yudong Li
Yudong Li is a scholar working on Cancer Research, Oncology and Infectious Diseases, having authored 34 papers that have together received 907 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (4 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (98 citations), Cancer Research (120 citations) and Oncology (180 citations). Yudong Li has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Xinle Liang, Shunying Li, Yuan Xu, Qiang Zhou, Pei Li, Yibo Gan, Songtao Li, Yujie Liu, Herui Yao and Yiqi Tang. Their work appears in journals such as Advanced Materials, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.